Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07HBQ
|
||||
| Former ID |
DNC008933
|
||||
| Drug Name |
N,N,N-Triisobutyl-pyrimidine-2,4,6-triamine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529687] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H31N5
|
||||
| Canonical SMILES |
CC(C)CNC1=CC(=NC(=N1)NCC(C)C)NCC(C)C
|
||||
| InChI |
1S/C16H31N5/c1-11(2)8-17-14-7-15(18-9-12(3)4)21-16(20-14)19-10-13(5)6/h7,11-13H,8-10H2,1-6H3,(H3,17,18,19,20,21)
|
||||
| InChIKey |
HVZSNANIMUMCPH-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor | Target Info | Inhibitor | [529687] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| Plasma membrane estrogen receptor signaling | |||||
| LKB1 signaling events | |||||
| Regulation of Telomerase | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| FOXM1 transcription factor network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| FOXA1 transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.